Associate Chief Physician, Department of Thoracic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Specializes in surgical treatment of lung cancer, esophageal cancer, and various mediastinal tumors, particularly minimally invasive thoracoscopic surgery; skilled in precise diagnosis of pulmonary nodules (especially ground-glass nodules) and determination of surgical timing; Has long been engaged in clinical work in thoracic surgery, particularly the surgical treatment of common thoracic tumors such as lung cancer, esophageal cancer, and mediastinal tumors. Since 2013, has actively promoted uniportal thoracoscopic surgery, making surgical treatment more minimally invasive, with the proportion of uniportal thoracoscopic surgery currently exceeding 90%. In recent years, has focused on precise diagnosis and minimally invasive surgery for early-stage lung cancer and esophageal cancer, particularly utilizing thoracoscopy, radiofrequency ablation, and other methods for the treatment of pulmonary ground-glass nodules, and in collaboration with the Endoscopy Center of the Gastroenterology Department, performing endoscopic ESD or total thoracoscopic radical resection for early-stage esophageal cancer. Meanwhile, for patients with advanced lung cancer and esophageal cancer, develops individualized comprehensive treatment plans, and under the guidance of multidisciplinary discussions, completes the full-process tumor treatment of neoadjuvant therapy + surgery + adjuvant therapy, achieving satisfactory outcomes for a large number of patients. Performs hundreds of various thoracic surgical procedures annually, including minimally invasive thoracoscopic surgery for lung cancer, esophageal cancer, mediastinal tumors, and various benign chest diseases (esophageal leiomyoma, hiatal hernia, achalasia, palmar hyperhidrosis, etc.). Surgical difficulty and surgical quality (including uniportal thoracoscopic lobectomy/segmentectomy, sleeve lobectomy, total thoracoscopic radical esophagectomy, single-port transxiphoid total thymectomy, etc.) are all in a leading position domestically, with low complication rates and satisfactory surgical outcomes, earning recognition from a large number of patients.